15018AST
Astec® CHIROBIOTIC® V2 Chiral (5 μm) HPLC Columns
L × I.D. 10 cm × 2.1 mm, HPLC Column
Sinónimos:
CHIROBIOTIC V2 Chiral Chromatography Column
About This Item
product name
Columna para HPLC quiral Astec® CHIROBIOTIC® V2, 5 μm particle size, L × I.D. 10 cm × 2.1 mm
material
stainless steel column
agency
suitable for USP L88
description
HPLC column
product line
Astec®
packaging
pkg of 1 ea
manufacturer/tradename
Astec®
parameter
0-45 °C temperature
241 bar pressure (3500 psi)
technique(s)
HPLC: suitable
LC/MS: suitable
L × I.D.
10 cm × 2.1 mm
matrix
High-purity silica gel particle platform
fully porous particle
matrix active group
vancomycin phase
particle size
5 μm
pore size
200 Å
operating pH range
3.5-7.0
separation technique
chiral
¿Está buscando productos similares? Visita Guía de comparación de productos
General description
- Fase ligada: vancomicina
- Intervalo de pH de funcionamiento: 3,5 - 7,0
- Diámetro de partícula: 5, 10 o 16 μm
- Tamaño de poro: 100 Å (CHIROBIOTIC® V) o 200 Å (CHIROBIOTIC® V2)
Preguntas frecuentes sobre CHIROBIOTIC
Referencias bibliográficas sobre CHIROBIOTIC
Bibliografía de productos quirales
Application
- Development and validation of an UFLC-MS/MS method for enantioselectivity determination of d,l-thero-methylphenidate, d,l-thero-ethylphenidate and d,l-thero-ritalinic acid in rat plasma and its application to pharmacokinetic study.: This study highlights the application of the Astec® CHIROBIOTIC® V2 chiral HPLC column in the pharmacokinetic assessment of chiral drugs, demonstrating its utility in accurate and efficient chiral separation for analytical chemistry in pharmacological research (Zhang et al., 2016).
- New high-performance liquid chromatography method for the determination of (R)-warfarin and (S)-warfarin using chiral separation on a glycopeptide-based stationary phase.: This paper describes a method using the Astec® CHIROBIOTIC® V2 chiral HPLC column to differentiate between the enantiomers of warfarin, showcasing its critical role in therapeutic drug monitoring and clinical pharmacology, which is essential for ensuring patient safety and efficacy in treatments (Malakova et al., 2009).
Legal Information
Choose from one of the most recent versions:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Contenido relacionado
Chromatograms
application for HPLCNuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico